Construction of a Hyperthermostable D-Allulose 3-Epimerase Using Arthrobacter globiformis M30

Heat is the real bottleneck

Many D-allulose 3-epimerases lose activity well before the reaction mixture gets interesting. Industrial bioconversion runs faster at high temperature. Substrate solubility rises, viscosity drops, and contamination risk falls. But enzymes denature. That is the trade-off every formulator knows.

A research team just broke that trade-off. They engineered a chimeric mutant—mutant E—from the D-allulose 3-epimerase of Arthrobacter globiformis M30 (AgDAE). The enzyme stays highly functional above 95°C and remains stable below 80°C. That is not a small step. It changes what a production process can look like.

Why thermostability wins

D-allulose is a rare sugar found in small quantities in nature. Food makers use it in reduced-sugar beverages, bakery, dairy, and confectionery. Demand keeps climbing. Buyers want consistent supply at competitive cost.

The enzymatic route is straightforward. D-Allulose 3-epimerase converts D-fructose into D-allulose by epimerization at the C-3 position. The problem is the enzyme's tolerance. Most variants struggle at the temperatures where fructose solutions behave best. Process engineers end up using more enzyme, running longer cycles, or fighting contamination.

A thermostable enzyme removes those limits. Higher temperature means faster kinetics. Faster kinetics means smaller reactors for the same output. A catalyst that survives longer also cuts enzyme loading per batch.

What the researchers built

The team started with AgDAE from Arthrobacter globiformis M30. They applied protein engineering to construct a chimeric mutant with enhanced structural rigidity. The goal was simple: keep the catalytic core intact while making the whole molecule resistant to thermal unfolding.

Then they measured the kinetic consequences.

What the data shows

Mutant E's kcat toward D-fructose is more than twice that of wild-type AgDAE. Catalytic efficiency, expressed as kcat/Km, also improved. The enzyme turns substrate over faster and does so more effectively. The stability profile is the headline.

Property	Mutant E	Wild-type AgDAE
Functional temperature	Above 95°C	Baseline
Stability window	Stable below 80°C	Baseline
kcat toward D-fructose	More than 2× wild-type	Baseline (1×)
Catalytic efficiency (kcat/Km)	Improved	Baseline

Those two numbers—95°C functional, 80°C stable—create a wide operating envelope. That gives process designers real freedom.

What this means for your process

This research is not isolated. Matsutani Chemical Industry has already used AgDAE to develop a scaled production system for D-allulose. They commercialized it under the brand name Astraea. The enzyme family has proven itself outside the lab.

Now layer a hyperthermostable mutant onto that platform. Higher operating temperature speeds throughput. Better stability simplifies storage, handling, and enzyme recycling. Each factor pulls down the cost per kilogram.

For ingredient buyers, the implication is strategic. Thermostable enzymes reduce batch failure risk. They make output more predictable. When a major player like Matsutani is already commercializing this enzyme lineage, the path from paper to product is short.

One caveat: the study reports enzyme performance, not full process economics. You still need to test the mutant in your own substrate stream, with your own impurities and operating schedule. But the starting point is strong.

FAQ

Is mutant E the same enzyme used in Astraea? It is related. The study builds on AgDAE, the enzyme behind Matsutani's Astraea production system. Mutant E is an engineered variant of that lineage. The commercial process and the research mutant are not identical.

What temperatures can the mutant tolerate? Mutant E remains highly functional above 95°C and is stable below 80°C. Those conditions would denature most conventional epimerases.

Does higher kcat mean lower enzyme cost? Not automatically. kcat measures turnover rate, not total productivity. But a more than twofold higher kcat, combined with improved catalytic efficiency and thermostability, points toward lower enzyme usage per kilogram. Process validation will tell you the real number.

The paper is published in FEBS Open Bio under DOI 10.1002/2211-5463.70060. Formulators and buyers tracking the allulose market should read it with their own process conditions in mind. The enzyme is ready. The question is whether your process is ready for the enzyme.